Calliditas - Year-End Report, 2022 ...Middle East

PR Newswire - News
2022: Successful transformation into a commercial stage company STOCKHOLM, Feb. 23, 2023 /PRNewswire/ -- "2022 was a fantastic year for Calliditas as we launched TARPEYO® in the US, the first approved drug for IgA nephropathy and a medication with the potential to be disease modifying...

Hence then, the article about calliditas year end report 2022 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Calliditas - Year-End Report, 2022 )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News


Latest News